Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant

The BioInnovation Institute (BII) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with DKK 3.5M to advance pre-clinical development of dendritic cell reprogramming and define its regulatory roadmap towards the clinic.

Swedish project funded with DKK 3.5M in PreSeed program